TY - JOUR
T1 - Burden of Valvular Heart Diseases in Hispanic/Latino Individuals in the United States
T2 - The Echocardiographic Study of Latinos
AU - Rubin, Jonathan
AU - Aggarwal, Shivani R.
AU - Swett, Katrina R.
AU - Kirtane, Ajay J.
AU - Kodali, Susheel K.
AU - Nazif, Tamim M.
AU - Pu, Min
AU - Dadhania, R.
AU - Kaplan, Robert C.
AU - Rodriguez, Carlos J.
N1 - Publisher Copyright:
© 2019
PY - 2019/8
Y1 - 2019/8
N2 - Objective: To explore the burden and clinical correlates of valvular heart disease in Hispanics/Latinos in the United States. Patients and Methods: A total of 1818 individuals from the population-based study of Latinos/Hispanics from 4 US metropolitan areas (Bronx, New York; Chicago, Illinois; San Diego, California; and Miami, Florida) underwent a comprehensive clinical and echocardiographic examination from October 1, 2011, through June 24, 2014. Logistic regression analysis was used to examine the associations of clinical and sociodemographic variables with valvular lesions. Results: The mean age was 55.2±0.2 years; 57.4% were female. The prevalence of any valvular heart disease (AVHD) was 3.1%, with no considerable differences across sex, and a higher prevalence with increasing age. The proportion of US-born vs foreign-born individuals was similar in those with vs without AVHD (P=.31). The weighted prevalence of AVHD was highest in Central Americans (8.4%) and lowest in Mexicans (1.2%). Regurgitant lesions of moderate or greater severity were present in 2.4% of the population and stenotic lesions of moderate or greater severity in 0.2%. Compared with those without AVHD, individuals with AVHD were more likely to have health insurance coverage (59.6% vs 79.2%; P=.007) but similar income (P=.06) and educational status (P=.46). Univariate regression models revealed that regurgitant lesions were associated with lower body mass index whereas stenotic lesions were associated with higher body mass index. Conclusion: Our data provide the first population-based estimates of the prevalence of valvular heart disease in Hispanic/Latinos. Valvular heart disease is fairly common in the Hispanic/Latino population and may constitute an important public health problem.
AB - Objective: To explore the burden and clinical correlates of valvular heart disease in Hispanics/Latinos in the United States. Patients and Methods: A total of 1818 individuals from the population-based study of Latinos/Hispanics from 4 US metropolitan areas (Bronx, New York; Chicago, Illinois; San Diego, California; and Miami, Florida) underwent a comprehensive clinical and echocardiographic examination from October 1, 2011, through June 24, 2014. Logistic regression analysis was used to examine the associations of clinical and sociodemographic variables with valvular lesions. Results: The mean age was 55.2±0.2 years; 57.4% were female. The prevalence of any valvular heart disease (AVHD) was 3.1%, with no considerable differences across sex, and a higher prevalence with increasing age. The proportion of US-born vs foreign-born individuals was similar in those with vs without AVHD (P=.31). The weighted prevalence of AVHD was highest in Central Americans (8.4%) and lowest in Mexicans (1.2%). Regurgitant lesions of moderate or greater severity were present in 2.4% of the population and stenotic lesions of moderate or greater severity in 0.2%. Compared with those without AVHD, individuals with AVHD were more likely to have health insurance coverage (59.6% vs 79.2%; P=.007) but similar income (P=.06) and educational status (P=.46). Univariate regression models revealed that regurgitant lesions were associated with lower body mass index whereas stenotic lesions were associated with higher body mass index. Conclusion: Our data provide the first population-based estimates of the prevalence of valvular heart disease in Hispanic/Latinos. Valvular heart disease is fairly common in the Hispanic/Latino population and may constitute an important public health problem.
UR - http://www.scopus.com/inward/record.url?scp=85068214095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068214095&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2018.12.035
DO - 10.1016/j.mayocp.2018.12.035
M3 - Article
C2 - 31279542
AN - SCOPUS:85068214095
SN - 0025-6196
VL - 94
SP - 1488
EP - 1498
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 8
ER -